Interestingly, gliomas with larger tumor sizes were more prevalent to exhibit positive RBP4 expression compared with the smaller ones (P < 0.001, Table 1), indicating that RBP4 may participate in GBM progression. The gene discussed is RBP4; the disease is central nervous system cancer.